Sandbox:Preeti: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 364: | Line 364: | ||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
| | | | ||
! align="center" style="background:#DCDCDC;" + |[[Splenic marginal zone lymphoma]] | ! align="center" style="background:#DCDCDC;" + |[[Splenic marginal zone lymphoma]] | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
* Clonal rearrangements of the [[immunoglobulin]] genes (heavy and light chains) | * Clonal rearrangements of the [[immunoglobulin]] genes (heavy and light chains) | ||
** Deletion 7q21-32 | ** Deletion 7q21-32 | ||
** Translocations of the CDK6 gene located on 7q21 | ** Translocations of the CDK6 gene located on 7q21 | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* [[CD20]] | * [[CD20]] | ||
* [[CD79a]] | * [[CD79a]] | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Small [[lymphocytes]] | * Small [[lymphocytes]] | ||
* Transformed blasts | * Transformed blasts | ||
* Epithelial histocytes | * Epithelial histocytes | ||
* Plasmacytic differentiation of neoplastic cells | * Plasmacytic differentiation of neoplastic cells | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
| | | | ||
! align="center" style="background:#DCDCDC;" + |[[Nodal marginal zone B-cell lymphoma]] | ! align="center" style="background:#DCDCDC;" + |[[Nodal marginal zone B-cell lymphoma]] | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
* Stimulation of antigen receptor by autoantigen and co-stimulatory molecule CD40 | * Stimulation of antigen receptor by autoantigen and co-stimulatory molecule CD40 | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| + | | align="center" style="background:#F5F5F5;" + |+ | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Hemorrhage | * Hemorrhage | ||
* Dyspepsia | * Dyspepsia | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* AE1/AE3 | * AE1/AE3 | ||
* Expression of B-cell markers CD20, CD79a, CD10, CD23, and bcl-2 | * Expression of B-cell markers CD20, CD79a, CD10, CD23, and bcl-2 | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Follicular cells in reactive zone | * Follicular cells in reactive zone | ||
* Centrocyte like cells in marginal zone lymphoma | * Centrocyte like cells in marginal zone lymphoma | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
* Chronic infectious conditions or autoimmune processes, such as | |||
Chronic infectious conditions or autoimmune processes, such as | ** ''H pylori'' gastritis | ||
* ''H pylori'' gastritis | |||
* Hashimoto thyroiditis | * Hashimoto thyroiditis | ||
* Sjögren syndrome | * Sjögren syndrome | ||
Line 475: | Line 474: | ||
| | | | ||
! colspan="2" align="center" style="background:#DCDCDC;" + |Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) | ! colspan="2" align="center" style="background:#DCDCDC;" + |Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
| | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
| | | |
Revision as of 05:26, 3 January 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Category | Disease | Etiology | Mechanism | Clinical manifestations | Paraclinical findings | Gold standard | Associated findings | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lab findings | Imaging | ||||||||||||||||||||||||||||
Demography | History | Symptoms | Signs | CBC | PBS | LFT | PT/PTT | Immunochemistry | Histopathology | Other | |||||||||||||||||||
Inherited | Acquired | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | |||||||||||||||
HL | |||||||||||||||||||||||||||||
Hodgkin's Lymphoma | |||||||||||||||||||||||||||||
NHL | |||||||||||||||||||||||||||||
B Cell Lymphoma | Precursor B-cell lymphoblastic leukemia/lymphoma |
|
|||||||||||||||||||||||||||
Follicular lymphoma |
|
+ | + |
|
|
+ | |||||||||||||||||||||||
Mantle cell lymphoma |
|
|
Abdominal distention |
|
Generalized lymphadenopathy | + |
|
|
↓ | Nl to ↓ |
|
|
Elevated LDH | ||||||||||||||||
Diffuse large B cell lymphoma |
|
|
|
↓ | ↓ | Nl to ↓ |
|
Centroblastic
Immunoblastic
Anaplastic
|
|
||||||||||||||||||||
Category | Disease | Etiology | Inherited | Acquired | Demography | History | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | PBS | LFT | PT/PTT | Immunochemistry | Histopathology | Other lab findings | Imaging | Gold standard | Associated findings | |
Burkitt lymphoma |
|
|
|
|
|
||||||||||||||||||||||||
B cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
|
||||||||||||||||||||||||||||
Marginal zone lymphoma | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type |
|
|||||||||||||||||||||||||||
Splenic marginal zone lymphoma |
|
|
|||||||||||||||||||||||||||
Nodal marginal zone B-cell lymphoma |
|
+ |
|
|
|
| |||||||||||||||||||||||
Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) |
|
||||||||||||||||||||||||||||
Hairy cell leukemia |
|
|
|
||||||||||||||||||||||||||
Precursor T-cell lymphoblastic leukemia/lymphoma |
|
||||||||||||||||||||||||||||
Adult T cell leukemia/lymphoma | |||||||||||||||||||||||||||||
T cell lymphoma | Anaplastic large cell lymphoma | ||||||||||||||||||||||||||||
Cutaneous T-cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
|||||||||||||||||||||||||
Peripheral T-cell lymphoma | Subcutaneous panniculitis-like T-cell lymphoma | ||||||||||||||||||||||||||||
Hepatosplenic gamma-delta T-cell lymphoma | |||||||||||||||||||||||||||||
Enteropathy-type intestinal T-cell lymphoma | |||||||||||||||||||||||||||||
Extranodal T-cell lymphoma, nasal type | |||||||||||||||||||||||||||||
Angioimmunoblastic T-cell lymphoma | |||||||||||||||||||||||||||||
Peripheral T-cell lymphoma, unspecified |